Pregnant women and immunocompromised individuals face unique health challenges, especially when it comes to respiratory infections. But here's where it gets critical: despite the risks, many in these groups remain under-vaccinated, leaving them vulnerable to preventable diseases. This isn’t just a health gap—it’s a call to action. Join the National Foundation for Infectious Diseases (NFID) for an eye-opening discussion on why respiratory immunization is a lifeline for these populations. We’ll dive into the latest U.S. vaccination guidelines for COVID-19, influenza, respiratory syncytial virus (RSV), and pneumococcal disease, shedding light on why these vaccines are non-negotiable for maternal and immunocompromised health.
And this is the part most people miss: disparities in immunization coverage aren’t just numbers—they’re barriers that put lives at risk. Our expert panel, moderated by NFID Medical Director Robert (Bob) H. Hopkins, Jr., MD, will tackle these gaps head-on. Joining him are Kevin A. Ault, MD, Vice President of NFID and Chair of Obstetrics and Gynecology at Western Michigan University, and Camille N. Kotton, MD, Clinical Director of Transplant and Immunocompromised Host Infectious Diseases at Massachusetts General Hospital. Together, they’ll share evidence-based recommendations and practical strategies to boost vaccination rates in these vulnerable groups.
By the end of this session, you’ll walk away with:
- A clear understanding of current vaccine guidelines tailored for pregnant women and immunocompromised individuals.
- Insights into the disparities driving low immunization rates and why they matter.
- Actionable strategies to bridge the vaccination gap and protect those at highest risk.
Here’s the controversial question: Are we doing enough to prioritize these populations in our public health efforts? Or is there a systemic oversight that needs addressing? We’ll explore this and more, inviting you to join the conversation.
Participation is free, but pre-registration is a must. NFID, accredited by the Accreditation Council for Continuing Medical Education (ACCME), offers 1.0 AMA PRA Category 1 Credits™ for physicians. Don’t miss this chance to be part of a critical dialogue—register now and help shape the future of respiratory immunization for those who need it most.
